Disparities in cardiovascular disease risk in the United States

Garth Graham1

  • 1University of Florida Department of Medicine, PO Box 100227, Gainesville, FL 32610 USA. garth.graham@medicine.ufl.edu.

Current Cardiology Reviews
|November 25, 2014
PubMed

Insights

Racial and ethnic minorities in the U.S. face higher heart disease risks due to untreated risk factors and comorbidities. Addressing these disparities requires healthcare providers to understand unique population needs for better outcomes.

Area of Science:

  • Cardiovascular disease epidemiology
  • Health disparities research
  • Population health management

Background:

  • Heart disease risk assessment is crucial given minority population growth in the U.S.
  • Minority populations exhibit higher prevalence of unrecognized coronary artery disease risk factors, leading to increased morbidity and mortality.
  • Acute Coronary Syndrome (ACS) rates are elevated in minority communities, with higher risks of myocardial infarction (MI), rehospitalization, and death.

Purpose of the Study:

  • To review the current science on population-level differences in heart disease risk factors among U.S. racial and ethnic groups.
  • To highlight disparities in the recognition, treatment, and outcomes of cardiovascular conditions in minority populations.
  • To emphasize the need for culturally competent healthcare to mitigate heart disease disparities.

Main Methods:

  • Comprehensive narrative literature review.
  • Analysis of population-level data on risk factors, comorbidities, and treatment utilization.
  • Examination of disease presentation and prognosis across diverse racial and ethnic groups.

Main Results:

  • Minority patients with ACS receive less beneficial treatment like angiography and percutaneous coronary intervention.
  • Comorbidities such as hypertension and diabetes mellitus, combined with environmental factors, contribute significantly to heart failure (CHF) disparities.
  • Untreated risk factors and comorbidities in minority populations increase the likelihood of adverse cardiovascular outcomes.

Conclusions:

  • Healthcare providers must understand the unique attributes of diverse racial and ethnic communities, including disease presentation, risk factors, and treatment nuances.
  • Awareness of incidence, risk factor burdens, prognosis, and treatment differences is essential for mitigating racial and ethnic disparities in heart disease.
  • Tailored healthcare approaches are necessary to address the specific needs of minority populations and reduce cardiovascular health inequities.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.7K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
880
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
735
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K